What is STERIS's market cap?

STERIS (STE) has a market capitalization of $20.6B and trades on NYSE.

What is STERIS's revenue and profitability?

STERIS generated $5.9B in trailing twelve-month revenue with net income of $782.4M, representing a net margin of 13.2%. Gross margin stands at 44.2%, with free cash flow of $972.4M. These figures are based on the Q1 2026 filing.

Who are STERIS's competitors?

STERIS's key competitors include Sterigenics International, Inc., Fortive, Ecolab, and others. These companies compete in similar markets and product categories.

Where is STERIS headquartered?

STERIS is headquartered in Ireland and employs approximately 18,179 people. It has been publicly traded since 1992.

STERIS

STE

STERIS plc is a leading global provider of infection prevention and procedural products and services focused on healthcare, medical device, and pharmaceutical markets.

Market cap

$20.64B-7.0%

Revenue$5.9B+8.7%

Net income$782.4M+27.3%

Free cash flow$972.4M+25.0%

EPS (diluted)$7.93+28.1%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q4 2026 report

May 11, 2026

Revenue$1.6BMiss by $6.2M EPS$2.83Miss by $0.03

Read the full report

Next report

Aug 5, 2026 (In 1 week)

Revenue estimate$1.5B

EPS estimate$2.54

Financials

Q4 2026

Income statement

See full

Revenue$1.6B+7.3%

Gross profit$697.2M+8.8%

Operating income$316.8M+46.6%

Net income$220.2M+51.2%

EPS (diluted)$2.24+52.4%

Balance sheet

See full

Cash & equivalents$439.6M+156%

Total debt$2.1B-10.3%

Total equity$7.2B+8.8%

Total assets$10.7B+5.8%

Cash flow

See full

Operating cash flow$335.4M+28.6%

CapEx$90.2M+27.2%

Free cash flow$245.2M+29.1%

Valuation & ratios

Valuation

See full

Market cap$20.64B-7.0%

Enterprise value$22.28B-5.8%

P/E26.4×-7.7×

P/S3.5×-0.5×

Profitability

See full

Gross margin44.2%+0.2pp

Operating margin18.6%+2.7pp

Net margin13.2%+1.9pp

FCF margin16.4%+2.1pp

Returns & leverage

See full

Return on equity11.3%+1.8pp

Debt / equity0.3×-0.1×

Current ratio2.1×+0.1×

Segments

By product

See full

Service$745.0M+9.4%

Consumables$456.2M+6.4%

Capital equipment$387.0M+4.3%

By segment

See full

Healthcare Segment$1.1B+7.5%

AST$289.2M+5.6%

Competitors

By market cap

Stryker$120.60B-20.1%

3M$88.1B+9.4%

Ecolab$74.4B-3.1%

Boston Scientific$64.2B-57.9%

STERIS$20.6B-6.2%

Fortive$18.5B+6.5%

Baxter International$11.5B-18.7%

Sotera Health$5.0B+53.9%

By revenue growth

Boston Scientific+17.4%

Stryker+8.8%

STERIS+8.7%

Sotera Health+7.4%

Baxter International+5.1%

Ecolab+4.9%

Fortive+3.6%

3M+2.4%

By net margin

Boston Scientific17.26%+5.7pp

STERIS13.18%+1.9pp

Sotera Health9.91%+7.7pp

Baxter International-9.7%-4.5pp

Profile

STERIS plc is a leading global provider of infection prevention and procedural products and services focused on healthcare, medical device, and pharmaceutical markets. The company helps customers create a healthier and safer world through a unique mix of consumables, capital equipment, and outsourced services. Its core value proposition centers on supporting patient care through comprehensive sterilization, disinfection, and surgical solutions.

Competitive position

A leading global provider with a significant installed base of capital equipment and a comprehensive network of contract sterilization facilities.

GeographiesAmericas, Europe, Asia, Ireland

Customer segmentsHospitals, Pharmaceutical companies, Medical device OEMs

Business modelManufacturing, Outsourced services, Consumables, Maintenance and repair

SuppliersStainless and carbon steel suppliers, Organic and inorganic chemical producers, Ethylene oxide (EO) suppliers, Radioisotope cobalt-60 suppliers, Plastic component manufacturers

CustomersAcute care hospitals, Pharmaceutical manufacturers, Medical device OEMs, Ambulatory surgery centers

CountryIreland

Listed1992

Employees18.2K

CEODaniel A. Carestio

SectorHealthcare

IndustryMedical - Devices

Websitesteris.com

FilingsSEC EDGAR

Ask your AI about STERIS.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is STERIS's market cap?: STERIS (STE) has a market capitalization of $20.6B and trades on NYSE.
What is STERIS's revenue and profitability?: STERIS generated $5.9B in trailing twelve-month revenue with net income of $782.4M, representing a net margin of 13.2%. Gross margin stands at 44.2%, with free cash flow of $972.4M. These figures are based on the Q1 2026 filing.
Who are STERIS's competitors?: STERIS's key competitors include Sterigenics International, Inc., Fortive, Ecolab, and others. These companies compete in similar markets and product categories.
Where is STERIS headquartered?: STERIS is headquartered in Ireland and employs approximately 18,179 people. It has been publicly traded since 1992.